Scan to Download ios&Android APP

Trade Delcath Systems, Inc. - DCTH CFD

4.28
0.93%
0.36
Low: 4.26
High: 4.28
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 20:00

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading Conditions
Long position overnight fee -0.0225%
Short position overnight fee -0.0219%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 4.32
Open* 4.26
Day's Range* 4.26 - 4.26
1-Year Change* -1.62%
Volume N/A
Average Vol. (3m) 0.5997
52 wk Range N/A
Market Cap 38.6896
P/E Ratio N/A
Shares Outstanding 8597680
Revenue 3.805
EPS -3.80404
Dividend (Yield %) N/A
Beta 0.98574
Next Earnings Date Nov 7, 2022

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Aug 16, 2022 4.32 -0.06 -1.37% 4.38 4.40 4.26
Aug 15, 2022 4.41 -0.21 -4.55% 4.62 4.67 4.29
Aug 12, 2022 4.63 0.25 5.71% 4.38 4.79 4.27
Aug 11, 2022 4.38 0.20 4.78% 4.18 4.42 4.17
Aug 10, 2022 4.28 0.11 2.64% 4.17 4.30 4.17
Aug 9, 2022 4.18 0.01 0.24% 4.17 4.18 4.17
Aug 8, 2022 4.21 0.03 0.72% 4.18 4.27 4.18
Aug 5, 2022 4.28 0.15 3.63% 4.13 4.28 4.10
Aug 4, 2022 4.08 -0.10 -2.39% 4.18 4.22 3.99
Aug 3, 2022 4.21 0.05 1.20% 4.16 4.23 4.16
Aug 2, 2022 4.17 0.14 3.47% 4.03 4.31 4.03
Aug 1, 2022 4.07 0.07 1.75% 4.00 4.22 3.97
Jul 29, 2022 4.08 0.04 0.99% 4.04 4.09 3.93
Jul 28, 2022 4.06 0.09 2.27% 3.97 4.14 3.92
Jul 27, 2022 4.03 0.00 0.00% 4.03 4.15 3.92
Jul 26, 2022 4.18 0.26 6.63% 3.92 4.18 3.92
Jul 25, 2022 4.07 -0.17 -4.01% 4.24 4.24 3.94
Jul 22, 2022 4.16 -0.19 -4.37% 4.35 4.50 4.15
Jul 21, 2022 4.27 0.07 1.67% 4.20 4.32 4.16
Jul 20, 2022 3.87 0.05 1.31% 3.82 3.94 3.82

Delcath Systems, Inc. Events

Time (UTC) Country Event
Monday, November 7, 2022
13:30
  US
Q3 2022 Delcath Systems Inc Earnings Release
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 1.992 2.715 3.407 1.58 1.646 3.555
Revenue 1.992 2.715 3.407 1.58 1.646 3.555
Cost of Revenue, Total 0.55 0.701 1.009 0.719 0.64 0.671
Gross Profit 1.442 2.014 2.398 0.861 1.006 2.884
Total Operating Expense 18.432 41.191 31.601 21.488 22.949 28.086
Selling/General/Admin. Expenses, Total 9.434 9.684 9.819 11.279 11.108 13.637
Research & Development 8.448 10.495 19.65 9.49 11.201 13.778
Operating Income -16.44 -38.476 -28.194 -19.908 -21.303 -24.531
Interest Income (Expense), Net Non-Operating 12.797 -6.6 8.921 11.027 -3.007 -1.186
Other, Net -14.327 -0.041 0.051 0.002 0.154 0.068
Net Income Before Taxes -17.97 -45.117 -19.222 -8.879 -24.156 -25.649
Net Income After Taxes -17.97 -44.9735 -19.222 -8.879 -24.156 -25.649
Net Income Before Extra. Items -17.97 -44.9735 -19.222 -8.879 -24.156 -25.649
Net Income -17.97 -45.117 -19.222 -8.879 -24.156 -25.649
Total Adjustments to Net Income -0.001 -0.527 0 -0.055 0
Income Available to Common Excl. Extra. Items -17.971 -45.5005 -19.222 -8.879 -24.211 -25.649
Income Available to Common Incl. Extra. Items -17.971 -45.644 -19.222 -8.879 -24.211 -25.649
Diluted Net Income -17.971 -45.644 -19.222 -8.879 -24.211 -25.649
Diluted Weighted Average Shares 0 0.00002 0.03819 0.0259 2.89783 7.14575
Diluted EPS Excluding Extraordinary Items -1297550000 -2266500 -503.343 -342.819 -8.35488 -3.5894
Diluted Normalized EPS -1297550000 -1608860 -473.936 -342.819 -8.35488 -3.5894
Unusual Expense (Income) 20.311 1.123 0
Total Extraordinary Items -0.1435
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total revenue 0.388 0.536 0.522 2.108 0.378
Revenue 0.388 0.536 0.522 2.108 0.378
Cost of Revenue, Total 0.112 0.202 0.227 0.13 0.033
Gross Profit 0.276 0.334 0.295 1.978 0.345
Total Operating Expense 7.115 6.987 7.218 6.765 7.921
Selling/General/Admin. Expenses, Total 3.296 3.288 4.036 3.016 3.648
Research & Development 3.707 3.497 2.955 3.619 4.24
Operating Income -6.727 -6.451 -6.696 -4.657 -7.543
Interest Income (Expense), Net Non-Operating -0.041 -0.04 -0.42 -0.685 -0.645
Other, Net 0.021 0.061 -0.009 -0.005 -0.015
Net Income Before Taxes -6.747 -6.43 -7.125 -5.347 -8.203
Net Income After Taxes -6.747 -6.43 -7.125 -5.347 -8.203
Net Income Before Extra. Items -6.747 -6.43 -7.125 -5.347 -8.203
Net Income -6.747 -6.43 -7.125 -5.347 -8.203
Income Available to Common Excl. Extra. Items -6.747 -6.43 -7.125 -5.347 -8.203
Income Available to Common Incl. Extra. Items -6.747 -6.43 -7.125 -5.347 -8.203
Diluted Net Income -6.747 -6.43 -7.125 -5.347 -8.203
Diluted Weighted Average Shares 6.49692 6.68137 7.58764 7.81239 8.19048
Diluted EPS Excluding Extraordinary Items -1.03849 -0.96238 -0.93903 -0.68443 -1.00153
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -1.03849 -0.96238 -0.93903 -0.68443 -1.00153
Total Adjustments to Net Income 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 34.156 7.589 5.919 12.617 32.338 31.152
Cash and Short Term Investments 4.409 3.999 2.516 10.002 28.575 22.802
Cash & Equivalents 4.409 3.999 2.516 10.002 28.575 22.802
Total Receivables, Net 0.403 0.317 1.164 0.021 0.057 0.044
Accounts Receivable - Trade, Net 0.403 0.317 0.585 0.021 0.057 0.044
Total Inventory 0.66 1.248 0.858 0.654 0.855 1.412
Other Current Assets, Total 28.684 2.025 1.381 0.181 0.181 5.264
Total Assets 35.239 8.887 6.844 14.212 34.635 33.124
Property/Plant/Equipment, Total - Net 1.083 1.298 0.925 1.595 2.297 1.972
Property/Plant/Equipment, Total - Gross 4.886 5.174 5.232 6.797
Accumulated Depreciation, Total -3.803 -3.876 -4.307 -4.825
Total Current Liabilities 36.095 7.814 17.75 15.994 10.035 5.954
Accounts Payable 0.594 3.846 7.715 4.533 1.774 0.638
Accrued Expenses 2.042 2.539 3.434 7.611 5.736 3.974
Notes Payable/Short Term Debt 0 0 0 0 0 0.551
Current Port. of LT Debt/Capital Leases 13.343 0 2.038 0 2 0.621
Other Current Liabilities, Total 20.116 1.429 4.563 3.85 0.525 0.17
Total Liabilities 36.729 8.209 21.783 20.569 12.557 21.172
Total Long Term Debt 0 0 0 2 0 15.011
Other Liabilities, Total 0.634 0.395 4.033 2.575 2.522 0.207
Total Equity -1.49 0.678 -14.939 -6.357 22.078 11.952
Preferred Stock - Non Redeemable, Net 0 0 0 0 0 0
Common Stock 0.041 1.141 0.103 0.001 0.06 0.079
Additional Paid-In Capital 277.749 324.378 328.962 364.785 417.449 432.831
Retained Earnings (Accumulated Deficit) -279.188 -324.832 -344.054 -371.171 -395.327 -420.976
Treasury Stock - Common -0.051 -0.051 0
Other Equity, Total -0.041 0.042 0.05 0.028 -0.104 0.018
Total Liabilities & Shareholders’ Equity 35.239 8.887 6.844 14.212 34.635 33.124
Total Common Shares Outstanding 0 0.00033 0.01463 0.06709 5.9961 7.90673
Prepaid Expenses 1.759 2.67 1.63
Other Long Term Assets, Total 0
Long Term Debt 2 0 15.011
Total Preferred Shares Outstanding 0.01136
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 30.203 22.906 32.318 31.152 25.384
Cash and Short Term Investments 26.6 19.274 24.865 22.802 16.34
Cash & Equivalents 26.6 19.274 24.865 22.802 16.34
Total Receivables, Net 0.075 0.075 0.069 0.044 0.178
Accounts Receivable - Trade, Net 0.075 0.075 0.069 0.044 0.178
Total Inventory 1.109 1.221 1.238 1.412 2.011
Prepaid Expenses 1.622 1.497 1.63 1.63 1.63
Other Current Assets, Total 0.797 0.839 4.516 5.264 5.225
Total Assets 32.315 24.917 34.425 33.124 27.317
Property/Plant/Equipment, Total - Net 2.112 2.011 2.107 1.972 1.933
Property/Plant/Equipment, Total - Gross 6.845 6.789 6.91 6.797 6.781
Accumulated Depreciation, Total -4.733 -4.778 -4.803 -4.825 -4.848
Total Current Liabilities 10.096 5.741 5.361 5.954 8.662
Accounts Payable 1.234 1.224 1.187 0.638 1.243
Accrued Expenses 6.36 4.008 3.678 3.974 4.584
Notes Payable/Short Term Debt 0 0 0 0.551 0.315
Current Port. of LT Debt/Capital Leases 2 0 0 0.621 2.52
Other Current Liabilities, Total 0.502 0.509 0.496 0.17 0
Total Liabilities 12.309 9.758 22.699 21.172 22.092
Total Long Term Debt 0 2 15.436 15.011 13.308
Other Liabilities, Total 2.213 2.017 1.902 0.207 0.122
Total Equity 20.006 15.159 11.726 11.952 5.225
Common Stock 0.063 0.074 0.074 0.079 0.079
Additional Paid-In Capital 422.027 423.66 427.301 432.831 434.305
Retained Earnings (Accumulated Deficit) -402.074 -408.504 -415.629 -420.976 -429.179
Other Equity, Total -0.01 -0.071 -0.02 0.018 0.02
Total Liabilities & Shareholders’ Equity 32.315 24.917 34.425 33.124 27.317
Total Common Shares Outstanding 6.25126 7.34978 7.35629 7.90673 7.90673
Long Term Debt 2 15.436 15.011 13.308
Preferred Stock - Non Redeemable, Net 0 0 0 0
Total Preferred Shares Outstanding 0.01171 0.01171 0.01136 0.01136
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -17.971 -45.117 -19.222 -8.879 -24.156 -25.649
Cash From Operating Activities -14.213 -15.398 -14.732 -23.69 -22.868 -22.604
Cash From Operating Activities 0.305 0.31 0.444 0.212 0.167 0.146
Non-Cash Items 1.915 26.898 -7.726 -7.92 6.927 8.663
Changes in Working Capital 1.538 2.511 11.772 -7.103 -5.806 -5.764
Cash From Investing Activities -1.345 -0.524 -0.076 -0.024 -0.782 -0.143
Capital Expenditures -0.258 -0.524 -0.076 -0.024 -0.782 -0.143
Other Investing Cash Flow Items, Total -1.087
Cash From Financing Activities 7.409 -10.517 13.236 30.305 42.355 20.822
Financing Cash Flow Items -26.2 -4.966 0 26.475 -0.107 0
Issuance (Retirement) of Stock, Net 2.383 2.325 12.442 0.15 42.488 6.385
Issuance (Retirement) of Debt, Net 31.226 -7.876 0.794 3.68 -0.026 14.437
Foreign Exchange Effects -0.049 0.067 -0.174 0.014 -0.132 0.122
Net Change in Cash -8.198 -26.372 -1.746 6.605 18.573 -1.803
Cash Interest Paid 0.011 0.681
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -6.747 -13.177 -20.302 -25.649 -8.203
Cash From Operating Activities -4.567 -11.669 -16.193 -22.604 -6.375
Cash From Operating Activities 0.039 0.078 0.115 0.146 0.031
Non-Cash Items 2.186 3.853 6.47 8.663 1.805
Cash Interest Paid 0.003 0.004 0.26 0.681 0.411
Changes in Working Capital -0.045 -2.423 -2.476 -5.764 -0.008
Cash From Investing Activities -0.009 -0.088 -0.144 -0.143 -0.089
Capital Expenditures -0.009 -0.088 -0.144 -0.143 -0.089
Cash From Financing Activities 2.376 2.393 16.513 20.822 0
Issuance (Retirement) of Stock, Net 2.376 2.393 2.458 6.385 0
Issuance (Retirement) of Debt, Net 0 0 14.437 14.437
Foreign Exchange Effects 0.094 0.033 0.084 0.122 0.002
Net Change in Cash -2.106 -9.331 0.26 -1.803 -6.462
Financing Cash Flow Items 0 -0.382 0

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
427000+

Traders

71000+

Active clients monthly

$46000000+

Monthly investing volume

$17000000+

Withdrawn each month

Delcath Systems, Inc. Company profile

About Delcath Systems Inc

Delcath Systems, Inc. is an oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company is a specialty pharmaceutical and medical device company developing its products. The Company's lead product candidate is HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system) is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Delcath Systems Inc revenues increased 27% to $1.4M. Net loss applicable to common stockholders increased 18% to $20.3M. Revenues reflect Product revenue increase of 35% to $1.1M, Other revenue increase of 9% to $392K. Higher net loss reflects Research and development expenses increase from $3M to $8.3M (expense), Stock-based Compensation in SGA increase from $49K to $4.2M (expense), Selling.

Equity composition

Common Stock $.01 Par, 12/10, 70M auth., 43,028,146 issd., less 28,100 shares in Treas. @ $51.1M. Insiders control 1.42%. InitialPublic Offering 10/20/00, 1.2M Units (1 Common+ 1Redeemable Warrant) @ $6 by Whale Securities Co . 5/20/03,Company sold 677,419 Units (5 Common + 5 Warrants) @ $3.10/unit. 98.3. 04/14, 1-for-16 Reverse stock split.

Industry: Medical Prosthetics

1633 Broadway Ste 22C
NEW YORK
NEW YORK 10019-6708
US

Income statement

People Also Watch

Bitcoin to US Dollar

23,382.55 Price
-2.370% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 21:00 (UTC)
Spread 60.00

Still looking for a broker you can trust?

Join the 427.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading